Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...
These are the best vitamins and supplements for eye health, which are great for supporting your vision and helping you take ...
In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...
GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback